Paricalcitol

Paricalcitol is a lipid of Sterol Lipids (ST) class. Paricalcitol is associated with abnormalities such as Vitamin D Deficiency. The involved functions are known as Hypertrophy, Left Ventricular. Paricalcitol often locates in Blood.

Cross Reference

Introduction

To understand associated biological information of Paricalcitol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Paricalcitol?

Paricalcitol is suspected in Vitamin D Deficiency and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Paricalcitol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Paricalcitol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Paricalcitol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Paricalcitol?

There are no associated biomedical information in the current reference collection.

What genes are associated with Paricalcitol?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with Paricalcitol?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Paricalcitol

Download all related citations
Per page 10 20 50 100 | Total 375
Authors Title Published Journal PubMed Link
Stavenuiter AW et al. Protective Effects of Paricalcitol on Peritoneal Remodeling during Peritoneal Dialysis. 2015 Biomed Res Int pmid:26605330
Riccio E et al. Effect of paricalcitol vs calcitriol on hemoglobin levels in chronic kidney disease patients: a randomized trial. 2015 PLoS ONE pmid:25781618
Ritter CS et al. Differential expression and regulation of Klotho by paricalcitol in the kidney, parathyroid, and aorta of uremic rats. 2015 Kidney Int. pmid:25692955
Thethi TK et al. Effect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease. 2015 J. Diabetes Complicat. pmid:25633573
Bover J et al. Vitamin D, vitamin D receptor and the importance of its activation in patients with chronic kidney disease. 2015 Nefrologia pmid:25611831
Kröpelin TF et al. Number and frequency of albuminuria measurements in clinical trials in diabetic nephropathy. 2015 Clin J Am Soc Nephrol pmid:25568217
Trillini M et al. Paricalcitol for secondary hyperparathyroidism in renal transplantation. 2015 J. Am. Soc. Nephrol. pmid:25194004
Cozzolino M et al. Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study. 2014 Nephrol. Dial. Transplant. pmid:24500308
Wang AY et al. Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial. 2014 J. Am. Soc. Nephrol. pmid:24052631
Freundlich M et al. Paricalcitol downregulates myocardial renin-angiotensin and fibroblast growth factor expression and attenuates cardiac hypertrophy in uremic rats. 2014 Am. J. Hypertens. pmid:24072555